Arsenal Biosciences, Inc. logo

Arsenal Biosciences, Inc.

178 employees · est. 2019 · South San Francisco, United...

VS
TCR Cure logo

TCR Cure

51-200 employees · est. 2016

TCR Cure is the older company (2019 vs 2016).

Side-by-Side Comparison

Arsenal Biosciences, Inc. TCR Cure
Founded
2019 2016 older
Headquarters
South San Francisco, United States Not tracked yet
Employees
178 51-200
Industry
Biotechnology, Computing, Life Sciences Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series B Series C
Total Funding
$305.81M $70.00M
Funding Rounds
2 4
Services
Development of programmable cell therapies, Research on solid tumor cell therapies, Collaboration with pharmaceutical companies, Engineering of medicines targeting cancer Not tracked yet
Target Customers
Cancer patients, Healthcare providers, Biotechnology researchers, Pharmaceutical collaborators Not tracked yet
Taxonomy
Not tracked yet Not tracked yet
Website
arsenalbio.com tcrcure.com
Arsenal Biosciences, Inc. logo

About Arsenal Biosciences, Inc.

Arsenal Biosciences, Inc. is a pioneering clinical-stage company specializing in programmable cell therapy, aimed at advancing treatments for solid tumors. Since its founding in 2019, ArsenalBio is leveraging cutting-edge technologies, including precise CRISPR-enabled genome editing and integrated c...

TCR Cure logo

About TCR Cure

TCR Cure specializes in the research, development, and industrialization of tumor immune cell therapy technology, with a primary focus on engineered T cells. By advancing CAR-T, TCR-T, CAR-NK, and TIL immune cell therapy products, they enhance tumor cure rates while reducing mortality, recurrence, a...

We will tell you when either one moves

BounceWatch watches Arsenal Biosciences, Inc. and TCR Cure for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Arsenal Biosciences, I... and TCR Cure — by email.

Frequently Asked Questions

Arsenal Biosciences, Inc.. TCR Cure. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Arsenal Biosciences, Inc. has raised $305.81M while TCR Cure has raised $70.00M.
Arsenal Biosciences, Inc. and TCR Cure operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Arsenal Biosciences, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Arsenal Biosciences, Inc. on 3 Jul 2026, and TCR Cure on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes